small pharma

Sales & Marketing

Pre-commercial & Emerging pharma companies may not think they have the resources to match the launch strategies of big pharma.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.